Rick Doblin

Santa Cruz, California, USA

https://maps.org/about/staff

Rick Doblin, Ph.D, is the founder and executive director of the Multidisciplinary Association for Psychedelic Studies (MAPS), which he founded in 1986. Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Rick has appeared on countless media outlets and has...

Eliza Dushku Is Now a Psychedelic Therapist

Eliza Dushku has opened up about her journey to become a psychedelic therapist, crediting substances like MDMA and psilocybin for helping her heal from past...

Despite FDA setback, psychedelic pioneer is unfazed about MDMA's prospects

Rick Doblin has spent more than 30 years developing MDMA to win approval from the FDA, which rejected it earlier this month.

Lykos co-founder Doblin to step down after MDMA setback - Pharmaphorum

Lykos Therapeutics is slashing staff after the FDA turned down its MDMA-assisted therapy for PTSD, while founder Rick Doblin is stepping down.

Lykos to lay off 100 employees after MDMA drug setback; founder to exit board

... Rick Doblin will leave the board, the company said on Thursday, days after the U.S. FDA declined approval for its MDMA-based PTSD treatment.

A Therapist Responds to the MDMA Imbroglio - Lucid News

As MDMA/s potential FDA rescheduling approaches, there has been a sudden hullabaloo of negativity, false claims of risks, and undeserved criticism ...

The Emerging Landscape of Psychedelic Therapy: Education and Certification

The field of psychedelic therapy is witnessing a resurgence, driven by growing evidence of its potential to treat mental health conditions like PTSD, depression, and...

How 'Selling Out' helped psychedelic MDMA - The Mercury News

Rick Doblin first dreamed of the therapeutic potential of the psychedelic drug MDMA in a hippie house in downtown Santa Cruz, in an era when...

What the “Psychedelic Renaissance” Needs to Learn from Big Tobacco

It’s easy to take for granted the self-congratulatory vibe of the Psychedelic Science conference last year. The conference, put on by the Multidisciplinary Association for...

Remembering Lucid News Co-Founder, Ken Jordan

Ken Jordan, entrepreneur, publisher, editor, and journalist, passed away Sunday, May 12th at age 63. Among his many contributions to the psychedelic community, Ken was...

Lykos Therapeutics Highlights the Not-For-Profit to For-Profit Pipeline in Psychedelics

This article is an OpEd written by a satirist On January 5, 2024, the psychedelic sector juggernaut famously known as the Multidisciplinary Association for Psychedelic...

The Psychedelic Education Market in 2023 (PRO REPORT)

Note: Some of the information in this report is based on data that is not yet available to the public. Our sources were generous enough...

PT464 – Bessel van der Kolk, MD – Bodywork, Somatic Literacy, and Understanding Trauma: The Mind and Body Connection

In this episode, Kyle interviews Bessel van der Kolk, MD: pioneer clinician, researcher, and educator on traumatic stress; Founder of the Trauma Research Foundation; Professor...

SXSW’s 2024 Lineup Boasts 13 Panels on Psychedelics

Organizers at SXSW this week unveiled a slate of more than 450 sessions chosen for the conference set to kick off in March. Among them...

Navigating the Psychedelic Landscape: Q3 Psychedelic Industry Report

Psychedelic Industry Quarter Review and HighlightsPsychedelic ScienceSurveysResearchClinical TrialsMAPSRegulations and PoliticsUSStatesCanadaInternationalEvents & MediaBusinessCapitalStocks M&AQ3 Review and Highlights This past quarter has been, without a doubt, the...

Q3 Overview: The State of the Psychedelic Sector

This past quarter has been, without a doubt, the busiest and most transformative three months of this year— perhaps even of the entire history of...

PT451 - Federico Seragnoli - ALPS Conference 2023: A Window Into Switzerland's Psychedelic Scene

In this episode, Joe interviews Federico Seragnoli: coordinator of the ALPS Foundation, psychologist who works with patients undergoing compassionate use treatments with psychedelics, and Founder...

Australia's Largest Supplier Of Psylocibin & MDMA On The Psychedelic Renaissance

Currently working with Paul Stamets and Rick Doblin on multiple psilocybin and MDMA projects that could commercially globalize psychedelics on a ...

My Delirious Flow State at History's Largest Psychedelic Conference - Lucid News

A satirical wrap account of Psychedelic Science 2023, a massive psychedelic conference that brought together industries, researchers, ...

Integrating MAPS’ Psychedelic Science

I’m likely not alone in still integrating my experience at MAPS Psychedelic Science 2023. It was a sprawling, hyper-charged event. How do we make sense...

Report: Final Round-up from MAPS Psychedelic Science 2023

The MAPS 2023 Psychedelic Science conference wrapped up with a final day of talks on Friday. The presentations included insights into the impacts of legislation...

Report: Final Round-up from MAPS’s Psychedelic Science 2023

The MAPS’s 2023 Psychedelic Science conference wrapped up with a final day of talks on Friday. The presentations included insights into the impacts of legislation...

Report: Day 2 of MAPS’s Psychedelic Science 2023

The MAPS’ 2023 Psychedelic Science conference continued with its second full day of panel discussions, offering participants a view into a range of topics impacting...

Report: Day 2 of MAPS’s Psychedelic Science 2023

The MAPS’ 2023 Psychedelic Science conference continued with its second full day of panel discussions, offering participants a view into a range of topics impacting...

The Briefing, November 29th: An Unabashed Look at the State of the Industry

A Bit of a Preamble The world of psychedelics has been a bit of a rough ride lately, and it’s hard to always find positive...

Breaking Convention is No Conference for Suits

A kaleidoscopic flock of kindred spirits donning rainbow jackets and magic mushroom hats meanders towards me. The air is thick with the unmistakable aroma of...

Psychedelic Conference at Hogwarts

This past Bicycle Day weekend, the 6th iteration of Europe’s largest psychedelic research conference Breaking Convention took place at the University of Exeter in Devon,...

SXSW Hops on the Psychedelic Hype Train

This past weekend, the psychedelic community congregated in Austin to network, party, and one up each other on how much money their companies have lost...

A Tale of Two Strategies: Does COMPASS Have the Right One?

Two weeks ago, Tesla announced on Twitter that it would make charging networks available for free to all U.S. electric vehicles by the end of...

Where Did 2022 Take the Psychedelic Medicine Field?

Josh Hardman, the founder of Psychedelic Alpha, reviews the published findings of COMPASS Pathways’ Phase 2b clinical trial and its upcoming Phase 3 program. Psychedelic...

Could psychedelics be the secret to treating PTSD? - YouTube

Founder and Executive Director of MAPS Rick Doblin discusses a new study that supports the psychedelic MDMA as a treatment for PTSD on 'Kennedy.

Rick Doblin – The Balance at MAPS Between Public Benefit and Private Profit

MAPS founder and Executive Director Part of our Year in Review series Nearly 37 years after Rick Doblin founded MAPS in April 1986, the organisation’s...

Podcast 683 – Psychedelics & “Genius” &+ “Love”

Support Lorenzo on Patreon.comGuest speaker: Bruce DamerToday's podcast features two Palenque Norte talks that Bruce Damer gave at the 2022 Burning Man Festival.This talk was...

2022: The Year in Psychedelics (PRO REPORT)

Introduction How do you measure a year? Time? Worldly events? Personal growth? There are many things that you could measure the time of a year...

Episode 58 - Rick Doblin, PhD - MAPS: Past, Present and Future

Episode 58 - Rick Doblin, PhD - MAPS: Past, Present and Future This all new episode of the MAPS podcast needs no introduction. Our very...

Embracing Heart-Focused Policing

Thanks to your support, Sarko Gergerian is doing his usual police work by day — and by night he’s training to become certified in MDMA-assisted...

The World Science Festival: Five Questions for Producer Caitlin Riley

We talk with producer Caitlin Riley about getting Rick Doblin and Reggie Watts to talk psychedelics at the World Science Festival

Psychedelics Were the Hot Topic at This Year’s World Economic Forum

As the longest-running annual psychedelics conference, Horizons was once a pioneering opportunity to gather and learn about medicines. Now conferences have propagated around the world,...

MDMA-Assisted Psychotherapy for Alcohol Use Disorder with Dr. Ben Sessa

In this episode of the Psychedelic Medicine Podcast, Dr. Ben Sessa joins to share results of his investigation into MDMA-assisted psychotherapy for alcohol use disorder....

Psychedelics Were the Hot Topic at This Year’s World Economic Forum

As the longest-running annual psychedelics conference, Horizons was once a pioneering opportunity to gather and learn about medicines. Now conferences have propagated around the world,...

Psychedelic Titans with Mary-Elizabeth Gifford of Psyence Group

This week’s Psychedelic Titan is Mary-Elizabeth Gifford, Executive Vice President of Psyence Group. Psyence is a life science biotechnology company pioneering the use of natural...

Is This the End Of the Psychedelic PR Crisis?

For 50 years, psychedelic researchers have been battling a public relations crisis of epic proportions, but the tides are changing! Whether you are a veteran...

Celebrating the Psychedelic Dawn

Last December I attended the Horizons pre-conference all-day seminar on “Introduction To MDMA Therapy For Clinicians,” with Michael and Annie Mithoefer. Michael has for the...

States are embracing psychedelics, paving the way for FDA approval

Marcus Capone served as a Navy SEAL for thirteen years. He had survived seven combat deployments to both Iraq and Afghanistan. He was an elite...

Photos from Our Investor Event in San Francisco

Last night, along with Next Titan Capital, we co-hosted a fabulous event at The Battery in San Francisco. Thank you to everyone that attended and...

Jay Godfrey and Richard Meloff are Unleashing the Power of Psychedelic Therapy – Podcast Episode #8

Episode eight of season one of the Psychedelic Invest Podcast is now available everywhere you listen to podcasts. In this episode of the Psychedelic Invest,...

Introducing keynote speaker Rick Doblin | Special Sections | mtexpress.com

His primary goal: to make MDMA-assisted therapy available by prescription for people with post-traumatic stress disorder, anxiety, depression, ...

Weekly Psychedelic Links - May 2022

5.6.22 Cannabis Would You Smoke ‘Nuclear Weed’? You Might Already: Why Irradiated Cannabis Is Common (And Safe) (Forbes)...

This Month in Psychedelics - May 2022

Policy Rhode Island became the 19th state in the U.S. to legalize the possession, use, cultivation, and purchase of cannabis...

Danny Motyka Manufactures Psychedelics for the Masses – Podcast Episode #5

On the fifth episode of the Psychedelic Invest Podcast, the CEO of Psygen, Danny Motyka joins to talk about manufacturing psychedelics at scale. During the...

Psychedelic Therapy Training Programs Expand To Meet Demand

As states such as Oregon and Colorado pass measures to decriminalize psychedelic therapies and more than fifty publicly traded companies develop these treatments, the demand...

MAPS

Founder and Executive Director

Examining the Psychedelic Renaissance: 2020 MAPS Canada Webinar Series

May 26, 2020

Interdisciplinary Conference on Psychedelic Research 2020 (Haarlem, The Netherlands)

Sep 24, 2020

Psychedelic Drug Development Digital Summit

Oct 21, 2020

MDMA and Psychedelic Assisted Therapy: Ethics and Law

Nov 07, 2020

Psychedelic Renaissance? Update on Research and Progress Around the World

Nov 25, 2020

Sana Symposium

Sep 17, 2021

CATALYST Summit 2021: Psychedelic Medicine Global Conference

May 07, 2021

Last updated: Apr 16, 2021

Request Deletion